revised event impact scale (IER-S) clinical trials

Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.

This study looks at how parents and medical staff are affected by finding out their baby has a rare condition called Phenylketonuria (PKU) through newborn screening. The goal is to make this process better and offer more support.